HRTX - Heron Therapeutics misses by $0.17 beats on revenue February, 22 2019 08:46 AM Heron Therapeutics Inc. Heron Therapeutics (NASDAQ:HRTX): Q3 GAAP EPS of -$0.63 misses by $0.17. Revenue of $28.84M (+187.0% Y/Y) beats by $1.79M. Press Release More news on: Heron Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,